A myeloablative conditioning regimen consisting of cyclophosphamide, fludarabine and total body irradiation followed by the transplantation of unrelated donor double unit umbilical cord blood grafts for patients with hematological malignancy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ciclosporin; Ciclosporin; Cyclophosphamide; Filgrastim; Fludarabine; Mycophenolate mofetil; Mycophenolate mofetil
- Indications Acute biphenotypic leukaemia; Acute myeloid leukaemia; Chronic myeloid leukaemia; Cord blood stem cell transplant rejection; Graft-versus-host disease; Leukaemia; Myelodysplastic syndromes; Myeloid leukaemia; Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 12 Feb 2016 Biomarkers information updated
- 18 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.